Hercules is developing innovative, oral drug therapies for treatment of cancer and viral infections, by blocking the Aryl Hydrocarbon Receptor (AhR). Hercules has demonstrated that blocking the Aryl Hydrocarbon Receptor could:
enhance the response of the immune system to cancer
reduce tumor growth in multiple solid tumor models
may be combined to enhance the efficacy of other immuno-oncology drugs.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.